Curi/Atlas/OLIGOPEPTIDE-29
INCI · · CIR review pending · used in 3 products
올리고펩타이드-29

OLIGOPEPTIDE-29

Evidence level
moderate
EWG score
Comedogenic
Category

● Benefits

Benefits to be documented.

● Cautions

No known cautions documented in the catalog.

Where Curi finds it.